2025-03-11 04:03:51
Latest Post
NTPC Group to Invest Rs 96,000 Crore in Chhattisgarh
Arvind Fashions aims to expand its CLUB A stores across India
Somany Ceramics Elevates Luxury with the launch of Duragres 2025 Collection
Cosmo Films Bags SIES SOP Star Awards 2025 for Innovative Packaging Materials
Zaggle Prepaid Ocean Services Ltd receives 'Financial Institution of the Year' Award
Stock Report
Sanofi India Ltd Q2CY24 consolidated profit at Rs. 103.2 crores
Posted On : 2024-07-28 12:38:53( TIMEZONE : IST )
Sanofi India Limited has reported Consolidated financial results for the period ended June 30, 2024.
Financial Results (Q2 CY2024) - QoQ Comparison
The company has reported total income of Rs. 468.3 crores during the period ended June 30, 2024 as compared to Rs. 514.3 crores during the period ended March 31, 2024.
The company has posted net profit / (loss) of Rs. 103.2 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs. 136.6 crores for the period ended March 31, 2024.
The company has reported EPS of Rs. 44.81 for the period ended June 30, 2024 as compared to Rs. 59.31 for the period ended March 31, 2024.
| Financials | Q2 CY2024 | Q1 CY2024 | % Change |
| Total Income | ₹468.3 crs | ₹514.3 crs |  -8.94% |
| Net Profit | ₹103.2 crs | ₹136.6 crs | -24.45% |
| EPS | ₹44.81 | ₹59.31 | -24.45% |
Financial Results (Q2 CY2024) - YoY Comparison
The company has reported total income of Rs.468.3 crores during the period ended June 30, 2024 as compared to Rs.530.4 crores during the period ended June 30, 2023.
The company has posted net profit / (loss) of Rs.103.2 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs.122.9 crores for the period ended June 30, 2023.
The company has reported EPS of Rs.44.81 for the period ended June 30, 2024 as compared to Rs.53.37 for the period ended June 30, 2023.
| Financials | Q2 CY2024 | Q2 CY2023 | % Change |
| Total Income | ₹468.3 crs | ₹530.4 crs | -11.71% |
| Net Profit | ₹103.2 crs | ₹122.9 crs | -16.03% |
| EPS | ₹44.81 | ₹53.37 | -16.04% |
Financial Results (Half Year Ended CY2024) - YoY Comparison
The company has reported total income of Rs.982.6 crores during the 6 Months period ended June 30, 2024 as compared to Rs.1077.4 crores during the 6 Months period ended June 30, 2023.
The company has posted net profit / (loss) of Rs.239.8 crores for the 6 Months period ended June 30, 2024 as against net profit / (loss) of Rs.313.3 crores for the 6 Months period ended June 30, 2023.
The company has reported EPS of Rs.104.12 for the 6 Months period ended June 30, 2024 as compared to Rs.136.04 for the 6 Months period ended June 30, 2023.
| Financials | Half Year Ended CY2024 | Half Year Ended CY2023 | % Change |
| Total Income | ₹982.6 crs | ₹1077.4 crs | -8.80% |
| Net Profit | ₹239.8 crs | ₹313.3 crs | -23.46% |
| EPS | ₹104.12 | ₹136.04 | -23.46% |
Shares of Sanofi India Limited was last trading in BSE at Rs. 6690.85 as compared to the previous close of Rs. 6710.15. The total number of shares traded during the day was 1390 in over 450 trades.
The stock hit an intraday high of Rs. 6900.00 and intraday low of 6617.00. The net turnover during the day was Rs. 9420927.00.
